Titov A.; Valiullina A.; Zmievskaya E.; Zaikova E.; Petukhov A.; Miftakhova R.; Bulatov E.; Rizvanov A.
(2020)
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Chimeric antigen receptor (CAR) immunotherapy is one of the most promising modern approaches for the treatment of cancer. To date only two CAR T-cell products, ...